Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Third Amended and Restated Certificate of Incorporation of the Registrant As Currently In Effect
- 3.2 Bylaws of the Registrant As Currently In Effect
- 3.5 Articles of Incorporation Bylaws
- 4.1 Specimen Certificate Representing Shares of Common Stock of the Registrant
- 4.4 Form of Warrant to Purchase Common Stock Issued Pursuant to 2013 2014 Bridge Financing
- 4.5 Form of Warrant to Purchase Common Stock Issued Pursuant to 2015 Warrant Exercise Program
- 4.6 Form of Senior Promissory Note Issued Pursuant to Securities Purchase Agreement Dated July 10 2013
- 4.7 Form of Convertible Promissory Note
- 4.8 Form of Promissory Note Issued by the Registrant to Certain Members of the Board of Directors
- 4.9 Instruments Defining the Rights of Security Holders, Including Indentures Instruments Defining the Rights of Security Holders, Including Indentures
- 10.1 Endra Inc. Second Amended and Restated 2013 Stock Incentive Plan
- 10.2 Form of Non Qualified Stock Option Award Under Second Amended and Restated 2013 Stock Incentive Plan
- 10.3 Form of Incentive Stock Option Agreement Under Second Amended and Restated 2013 Stock Incentive Plan
- 10.7 Material Contracts
- 10.8 Material Contracts
- 10.9 Material Contracts
- 10.10 Material Contracts
- 10.11 Material Contracts
- 10.12 Material Contracts
- 10.13 Material Contracts
- 10.14 Material Contracts
- 10.15 Material Contracts
- 10.16 Material Contracts
- 10.17 Material Contracts
- 10.18 Material Contracts
- 10.19 Material Contracts
- 10.20 Material Contracts
- 23.1 Consent of RBSM LLP Independent Registered Public Accounting Firm
NDRA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the reference to our firm under the caption “Experts” and the use of our report dated July 15, 2016 (except for the effect of the restatement discussed in Note 3 to the financial statements, for which the date is August 4, 2016), which includes an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern, on the financial statements of ENDRA Life Sciences, Inc. which appears in this Registration Statement on Form S-1.
/s/ RBSM LLP
Henderson, Nevada
November 18, 2016